Correlation Between Stoke Therapeutics and Gracell Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Gracell Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Gracell Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Gracell Biotechnologies, you can compare the effects of market volatilities on Stoke Therapeutics and Gracell Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Gracell Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Gracell Biotechnologies.
Diversification Opportunities for Stoke Therapeutics and Gracell Biotechnologies
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Stoke and Gracell is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Gracell Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gracell Biotechnologies and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Gracell Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gracell Biotechnologies has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Gracell Biotechnologies go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Gracell Biotechnologies
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 2.02 times less return on investment than Gracell Biotechnologies. But when comparing it to its historical volatility, Stoke Therapeutics is 1.09 times less risky than Gracell Biotechnologies. It trades about 0.04 of its potential returns per unit of risk. Gracell Biotechnologies is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 251.00 in Gracell Biotechnologies on August 30, 2024 and sell it today you would earn a total of 151.00 from holding Gracell Biotechnologies or generate 60.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 31.31% |
| Values | Daily Returns |
Stoke Therapeutics vs. Gracell Biotechnologies
Performance |
| Timeline |
| Stoke Therapeutics |
| Gracell Biotechnologies |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Stoke Therapeutics and Gracell Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Gracell Biotechnologies
The main advantage of trading using opposite Stoke Therapeutics and Gracell Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Gracell Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gracell Biotechnologies will offset losses from the drop in Gracell Biotechnologies' long position.| Stoke Therapeutics vs. Bright Minds Biosciences | Stoke Therapeutics vs. HP Inc | Stoke Therapeutics vs. Intel | Stoke Therapeutics vs. Chevron Corp |
| Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |